0:000:00
<p>Dr. Monty Pal and Dr. Pauline Funchain discuss the latest efforts to diagnose, prevent, and treat the series of immune-related adverse events that have emerged in the era of immunotherapy.</p> <p><span style= "text-decoration: underline;"><strong>TRANSCRIPT</strong></span></p> <p class="MsoNormal"><strong><span style= "font-family: 'Calibri',sans-serif;">Dr. Monty Pal:</span></strong> <span style="font-family: 'Calibri',sans-serif;">Hello, and welcome to the <em>ASCO Daily News</em> Podcast. I am Monty Pal, a medical oncologist, professor and vice chair of medical oncology at the City of Hope Comprehensive Cancer Center in Los Angeles, California.</span></p> <p class="MsoNormal"><span style= "font-family: 'Calibri',sans-serif;">Now, it is probably no surprise to this audience that immunotherapy has transformed the treatment landscape for multiple cancer types. It remains a pillar of modern oncology. Having said that, I think we have all been baffled by certain toxicities that we run...